BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 21816195)

  • 1. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.
    Van Damme P; Giaquinto C; Huet F; Gothefors L; Maxwell M; Van der Wielen M;
    J Infect Dis; 2007 May; 195 Suppl 1():S4-S16. PubMed ID: 17387650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age.
    Forster J; Guarino A; Parez N; Moraga F; Román E; Mory O; Tozzi AE; de Aguileta AL; Wahn U; Graham C; Berner R; Ninan T; Barberousse C; Meyer N; Soriano-Gabarró M;
    Pediatrics; 2009 Mar; 123(3):e393-400. PubMed ID: 19254975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of group A rotaviruses in children hospitalized with acute gastroenteritis in Norway, 2006-2008.
    Vainio K; Nordbø SA; Njølstad G; Størvold G; Døllner H; Midgaard C; Bosse FJ; Rognlien AG; Rojahn A; Wathne KO; Flem E
    J Med Virol; 2009 Oct; 81(10):1839-44. PubMed ID: 19697411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
    Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
    Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of rotavirus vaccination in Spain.
    Martinón-Torres F; Bouzón Alejandro M; Redondo Collazo L; Sánchez Lastres JM; Pértega Díaz S; Seoane Pillado MT; Martinón Sánchez JM;
    Hum Vaccin; 2011 Jul; 7(7):757-61. PubMed ID: 21521947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
    Patel MM; Tate JE; Selvarangan R; Daskalaki I; Jackson MA; Curns AT; Coffin S; Watson B; Hodinka R; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2007 Oct; 26(10):914-9. PubMed ID: 17901797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.